DNLI (STOCKS)
Denali Therapeutics Inc. Common Stock
$19.730000
-0.090000 (-0.45%)
Prev close: $19.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ryan J. Watts
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,073.97M
- Employees
- 517
- P/E (TTM)
- -6.76
- P/B (TTM)
- 3.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Assets | $1.06B |
| Current Assets | $882.60M |
| Noncurrent Assets | $173.02M |
| Fixed Assets | $53.73M |
| Other Non-current Assets | $119.29M |
| Liabilities | $129.42M |
| Current Liabilities | $90.15M |
| Accounts Payable | $6.75M |
| Wages | $18.36M |
| Other Current Liabilities | $65.04M |
| Noncurrent Liabilities | $39.28M |
| Equity | $926.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $926.20M |
| Liabilities And Equity | $1.06B |